Maspin is a tumour suppressor that inhibits breast cancer tumour metastasis in vivo.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 138732)

Published in Breast Cancer Res on May 16, 2002

Authors

Charles H Streuli1

Author Affiliations

1: School of Biological Sciences, University of Manchester, Oxford Road, Manchester M13 9PT, UK.

Articles cited by this

The hallmarks of cancer. Cell (2000) 113.05

Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol (2000) 13.29

MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell (1998) 9.70

The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell (1999) 6.08

ECM and cell surface proteolysis: regulating cellular ecology. Cell (1997) 6.00

Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science (1994) 5.37

Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci (2002) 4.25

Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci U S A (1997) 3.96

Matrix metalloproteinases in angiogenesis: a moving target for therapeutic intervention. J Clin Invest (1999) 3.35

Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution. J Cell Biol (1992) 3.29

Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes. Clin Cancer Res (2000) 3.03

The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell (2001) 2.97

A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis (1999) 2.93

Maspin is an angiogenesis inhibitor. Nat Med (2000) 2.40

Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci U S A (1996) 2.20

Extracellular matrix remodelling and cellular differentiation. Curr Opin Cell Biol (1999) 2.14

The human myoepithelial cell is a natural tumor suppressor. Clin Cancer Res (1997) 2.08

Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J Cell Biol (2000) 2.07

Further evidence to support the melanocytic origin of MDA-MB-435. Mol Pathol (2002) 2.04

Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol (1998) 1.95

Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol (2001) 1.82

Requirement of basement membrane for the suppression of programmed cell death in mammary epithelium. J Cell Sci (1996) 1.80

Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest (2001) 1.71

p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem (2000) 1.64

Epigenetic silencing of maspin gene expression in human breast cancers. Int J Cancer (2000) 1.56

Development of mammary preneoplasias in vivo from mouse mammary epithelial cell lines in vitro. Cancer Res (1992) 1.49

The mammary myoepithelial cell--Cinderella or ugly sister? Breast Cancer Res (2000) 1.46

Role of morphogenetic factors in metastasis of mammary carcinoma cells. Oncogene (1998) 1.38

Production, purification, and characterization of recombinant maspin proteins. J Biol Chem (1994) 1.38

Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J Biol Chem (2001) 1.35

maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res (1998) 1.32

Evidence for a direct interaction between the tumor suppressor serpin, maspin, and types I and III collagen. J Biol Chem (2002) 1.23

Blocking tumor growth, invasion, and metastasis by maspin in a syngeneic breast cancer model. Cancer Res (2001) 1.22

The role of the plasminogen activation system in angiogenesis and metastasis. Surg Oncol Clin N Am (2001) 1.20

Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem (2001) 1.11

Cell-matrix interactions during development and apoptosis of the mouse mammary gland in vivo. Dev Dyn (2002) 1.07

Distribution of fibronectin on clonal cell lines of a rat mammary adenocarcinoma growing in vitro and in vivo at primary and metastatic sites. Cancer Res (1981) 1.02

Expression of the p53 and Maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer (2001) 1.02

Overexpression of urokinase receptor in breast cancer cells results in increased tumor invasion, growth and metastasis. Int J Cancer (1996) 1.02

The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells. Clin Exp Metastasis (1993) 0.99

Growth and metastasis of human breast cancers in athymic nude mice. Clin Exp Metastasis (1995) 0.93

Developmental biology: vasculogenesis is a wreck without RECK. Curr Biol (2002) 0.93

Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck (2001) 0.92

Maspin expression in myoepithelial tumors of the breast. Pathol Res Pract (2001) 0.90

Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model. Oncogene (2001) 0.85

Characterization of brain and bone-metastasizing clones selected from an ethylnitrosourea-induced rat mammary carcinoma. Clin Exp Metastasis (1994) 0.80

Colonization characteristics of a murine mammary tumor cell line that metastasizes frequently to the heart. Clin Exp Metastasis (1991) 0.77